Publication

The formulation of hyperpolarized 13C pyruvate solutions influences the labeling of myocardial metabolites in vivo

Arnaud Comment
2016
Posters

Abstract

In developing an intact rat model for myocardial ischemia using hyperpolarized 13C pyruvate, different compound formulations were evaluated. Infusion of 4-hydroxy-TEMPO-polarized sodium [1-13C]pyruvate was compared to an equivalent dose of buffered trityl radical-polarized [1-13C]pyruvic acid. Whereas higher levels of polarization and MRS signal were obtained with trityl radical, the metabolite signals normalized to total signal were lower. In particular, [1-13C]lactate signal relative to total signal was markedly higher using TEMPO-polarized pyruvate. [13C]bicarbonate and [1-13C]alanine signals were affected to a lesser degree. This study demonstrates the composition of the infused hyperpolarized pyruvate solution can significantly affect its metabolism in vivo.

Official source

https://infoscience.epfl.ch/entities/publication/aafe5b95-7c2b-4af8-812c-fa668a9c4025

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Arnaud Comment
2016
Posters

Abstract

Official source

https://infoscience.epfl.ch/entities/publication/aafe5b95-7c2b-4af8-812c-fa668a9c4025

About this result

Related concepts (30)

Ischemia

Ischemia or ischaemia is a restriction in blood supply to any tissue, muscle group, or organ of the body, causing a shortage of oxygen that is needed for cellular metabolism (to keep tissue alive). Ischemia is generally caused by problems with blood vessels, with resultant damage to or dysfunction of tissue i.e. hypoxia and microvascular dysfunction. It also implies local hypoxia in a part of a body resulting from constriction (such as vasoconstriction, thrombosis, or embolism).

Myocardial infarction

A myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops in one of the coronary arteries of the heart, causing damage to the heart muscle. The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck or jaw. Often it occurs in the center or left side of the chest and lasts for more than a few minutes. The discomfort may occasionally feel like heartburn. Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat or feeling tired.

Coronary ischemia

Coronary ischemia, myocardial ischemia, or cardiac ischemia, is a medical term for a reduced blood flow in the coronary circulation through the coronary arteries. Coronary ischemia is linked to heart disease, and heart attacks. Coronary arteries deliver oxygen-rich blood to the heart muscle. Reduced blood flow to the heart associated with coronary ischemia can result in inadequate oxygen supply to the heart muscle.